Drug-eluting beadsversusconventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-eluting beadsversusconventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 31, Issue 3, Pages 645-653
Publisher
Wiley
Online
2015-09-03
DOI
10.1111/jgh.13147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical–Radiological Outcomes and Safety Profile
- (2014) Carlo Spreafico et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma
- (2014) Zhi-Bo Xie et al. HEPATOLOGY RESEARCH
- Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review
- (2013) Jean-Marc Idée et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
- (2012) Khairuddin Memon et al. JOURNAL OF HEPATOLOGY
- Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
- (2012) Myeong Jun Song et al. JOURNAL OF HEPATOLOGY
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations
- (2011) Riccardo Lencioni et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants
- (2011) Julien Namur et al. JOURNAL OF HEPATOLOGY
- Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
- (2011) Rodolfo Sacco et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started